SecBot SecBot
144 ·Filed Nov 13, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 8h ago SEC0001972481-26-000301
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine Form 144 tied to RSU vesting, not a discretionary sale. The small size relative to market cap and the officer's role suggest no material signal. Monitor for any subsequent Form 4 filings to confirm execution.

DirectionNeutral
Confidencehigh
Horizonimmediate
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

John Cox, an officer of Dyne Therapeutics, filed a Form 144 notice of intent to sell 5,513 shares of common stock, with an estimated aggregate market value of approximately $92,751 based on a price of $16.82 per share. The sale is related to the vesting of restricted stock units and represents a routine insider transaction for tax or diversification purposes.

Key Facts

  • Reporting person: John Cox, an officer of Dyne Therapeutics
  • Shares to be sold: 5,513 shares of common stock
  • Estimated aggregate market value: $92,751 (based on $16.82 per share)
  • Sale intended on or about 11/13/2026
  • Shares acquired via restricted stock units vesting on 11/13/2026
  • Broker: Stifel Nicolaus & Company Inc
  • Nature of transaction: equity compensation (RSU vesting)

Financial Impact

Approximately $92,751 in value, representing about 0.003% of Dyne's $3.4B market cap

dilution

Risk Factors

  • Insider selling ahead of material non-public information cannot be ruled out, but the filing is consistent with routine equity compensation
  • The sale may not occur; Form 144 is an intent to sell, not a completed transaction

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001972481-26-000301
Document: 0001972481-26-000301-index.html0001972481-26-000301
Document: 0001972481-26-000301.txt0001972481-26-000301

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Viewing Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens in 9h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026